FUT8 and non-small cell lung carcinoma: miR-198 also acts as a direct negative regulator of FUT8 expression both in a colorectal and a non-small cell lung cancer model, with miR-198 inhibition leading to an aggressive phenotype and a survival disadvantage [52,53].